POSITRON EMISSION TOMOGRAPHY SCANNERS MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Rising Acceptance of PET-CT Scanners in Oncology Settings

PET scanning technology has witnessed substantial evolution over the past decades. The emergence of hybrid PET-CT imaging, where both anatomical and metabolic information can be obtained from a single scan session, has remarkably increased the clinical applications of PET imaging. PET-CT is now considered the standard of care for accurate cancer staging, treatment planning, therapy response assessment and detecting relapse or metastasis. Its high diagnostic value in oncology compared to other conventional imaging modalities like CT, MRI or ultrasound has boosted installation of PET-CT systems globally. Moreover, oncologists are relying more on PET-CT for tumor imaging considering its ability to detect cancer recurrence earlier than other tests. Reimbursement policies in several countries now cover PET-CT for various cancer indications. Therefore, expanding clinical applications and growing insurance coverage for PET-CT scans in cancer management across hospitals and diagnostic centers worldwide can boost demand for PET scanners. Manufacturers are also introducing new generation PET-CT devices with faster acquisition time, enhanced resolution and throughput, and this boosts their adoption rate in clinical oncology practice.